Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

✍ Scribed by Birgitte B Rasmussen; Meredith M Regan; Anne E Lykkesfeldt; Patrizia Dell'Orto; Barbara Del Curto; Katrine L Henriksen; Mauro G Mastropasqua; Karen N Price; Eliane Méry; Magali Lacroix-Triki; Stephen Braye; Hans J Altermatt; Richard D Gelber; Monica Castiglione-Gertsch; Aron Goldhirsch; Barry A Gusterson; Beat Thürlimann; Alan S Coates; Giuseppe Viale

• Book ID: 117784565
• Publisher: The Lancet
• Year: 2008
• Tongue: English
• Weight: 213 KB
• Volume: 9
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(07)70386-8